GXCPC1

· Gwo Xi Stem Cell Applied Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GXCPC1, covering 2023-06-06 to 2023-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis [Phase 1, Phase 2]